Skip to main content

Table 8 Meaningful within-person thresholds of ASD total scores, Item 8, and Item 9

From: Development and evaluation of the Acromegaly Symptom Diary

Change in PGI-S

n

Change in ASD total from EOT to Week 17

   
  

Mean ± SD

Q1, Median, Q3

Min, Max

95% CI

1-point improvement

2

− 3.64 ± 5.76

− 7.71, − 3.64, 0.43

− 7.71, 0.43

− 55.38 to 48.09

No difference

15

1.12 ± 4.50

− 1.12, 0.50, 4.21

− 8.29, 7.86

− 1.37 to 3.61

1-point worsening

7

5.05 ± 5.01

0.14, 3.71, 9.14

− 0.29, 12.43

0.42 to 9.68

2-point worsening

1

8.57 (−)

8.57, 8.57, 8.57

8.57, 8.57

NA

 Change in sleep difficulty (Item 8) From EOT to Week 17

     

3-point improvement

0

NA

NA

NA

NA

2-point improvement

0

NA

NA

NA

NA

1-point improvement

2

− 1.50 ± 1.92

− 2.86, −  1.50, −  0.14

− 2.86, −  0.14

− 18.74 to 15.74

No difference

15

− 0.39 ± 1.66

− 0.57, 0.00, 0.43

− 5.86, 1.57

− 1.30 to 0.53

1-point worsening

7

0.69 ± 0.97

0.00, 0.00, 1.95

0.00, 2.14

− 0.21 to 1.58

2-point worsening

1

0.00 (-)

0.00, 0.00, 0.00

0.00, 0.00

NA

3-point worsening

0

NA

NA

NA

NA

 Change in Short-Term Memory (Item 9) From EOT to Week 17

     

3-point improvement

0

NA

NA

NA

NA

2-point improvement

0

NA

NA

NA

NA

1-point improvement

1

− 2.00 (-)

− 2.00, −  2.00, −  2.00

− 2.00, −  2.00

NA

No difference

10

0.19 ± 1.80

− 0.14, 0.20, 1.23

− 4.00, 3.00

− 1.10 to 1.47

1-point worsening

4

− 0.01 ± 0.21

− 0.14, 0.00, 0.12

− 0.29, 0.24

− 0.35 to 0.33

2-point worsening

0

NA

NA

NA

NA

3-point worsening

0

NA

NA

NA

NA

  1. ASD = Acromegaly Symptom Diary; CI = confidence interval; EOT = end of treatment; max = maximum; min = minimum; NA = not assessed; PGI-S = Patient Global Impression of Severity; Q1 = quartile 1 (25th percentile); Q3 = quartile 3 (75th percentile)
  2. Groups with an n of 0 were omitted from the table.